6-Bromoisoquinolin-3-amine is employed in the comprehensive structure-activity relationship studies to identify the allosteric inhibitors that exhibit selective recognition of protein arginine methyltransferase PRMT3 in human cells.
参考文献
Kaniskan, H. U., et al.: J. Med. Chem., 61, 1204 (2018)
沪ICP备17019645号
400-821-0725
